Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.
Atherosclerosis
Atherosclerosis
Article
Drug-coated Balloons short
Article
Statins and Insulin Resistance
Read time: 1h 1m 1s
About
Media
Watch time: 4m 53s
Watch time: 4m 57s
Watch time: 8m 2s
Watch time: 3m 25s
Watch time: 4m 43s
Watch time: 4m 14s
Watch time: 7m 48s
Watch time: 7m 44s
Watch time: 10m 34s
Watch time: 9m 40s
Articles
Effects of Reconstituted High-density Lipoprotein Infusions on Coronary Atherosclerosis
Citation:
US Cardiology 2007;4(2):32–4
- Views:
117
- Downloads:
0
Homocysteine-lowering Treatment in Reduction of Stroke and Coronary Vascular Risk - Do Not Give Up
Citation:
US Cardiology 2009;6(1):36–40
- Views:
164
- Downloads:
0
Do Childhood Risk Factors Affect Arterial Structure and Function?
Citation:
Asia-Pacific Cardiology 2007;1(1):14-6
- Views:
51
- Downloads:
0
European Physicians Perspectives on Cholesterol Management and Inhibition of Cholesterol Absorption and Production
Citation:
European Cardiovascular Disease 2007;3(1):16–20
- Views:
237
- Downloads:
0